New Queen Elizabeth Hospital

Birmingham B15 2WB

0 studies enrolling now · 2 studies all time

What they study most

Gastric Adenocarcinoma, Primary Sclerosing Cholangitis (PSC)

Studies at this site

• Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma — Completed
• Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC) — Completed